FDA Class I Recall of Ashfiat Alharamain Energy Support Expanded
An ongoing Class I recall of Ashfiat Alharamain Energy Support due to undeclared tadalafil covers 1,052 units distributed nationwide.
4 reports on this incident · first at Aug 18, 2026, 10:13 a.m. ET
This recall is open. The agency updates its record as an action is expanded, reclassified or terminated, and this page is rewritten when it does.
We last searched for new coverage of this at Aug 18, 2026, 3:07 a.m. ET — checked 8h ago.
Earlier reports
Aug 18, 2026, 10:56 a.m. ET
FDA Classifies Ashfiat Alharamain Energy Support Recall as Class I
On August 12, 2026, the U.S. Food and Drug Administration classified the recall of Ashfiat Alharamain Energy Support as Class I. According to FDA background guidelines, a Class I classification is the agency's most serious category, reserved for situations where there is a reasonable probability that using or exposure to the product will cause serious adverse health consequences or death.
The recall, tracked under recall number H-1196-2026, affects 1052 units of Ashfiat Alharamain Energy Support 250ml/8fl. oz. FDA official enforcement records list the firm as AKKARCO LLC and state the recall was initiated on January 28, 2026, due to undeclared tadalafil. The product was distributed nationwide through third-party e-commerce marketplace Amazon.com. Affected units carry Batch No: ENGOT24, EXP: OCT 2028, and UPC: 1234561870003.
According to reporting and FDA notifications, the item is a finished retail honey-based product sold in 250 ml (8 fl oz) jars marketed to consumers for energy support. Agency records show no other enforcement actions on file for AKKARCO LLC. The status of the recall remains listed as ongoing.
Aug 18, 2026, 10:29 a.m. ET
FDA Closes Recall of Ashfiat Alharamain Energy Support
On August 12, 2026, Food and Drug Administration enforcement records reflected that the agency has closed its recall action for Ashfiat Alharamain Energy Support, indicating that regulators consider the recall carried out. The recall, listed under recall number H-1196-2026, was initially initiated on January 28, 2026, by AKKARCO LLC.
FDA records designated the action as a Class I recall involving 1,052 units of Ashfiat Alharamain Energy Support in 250ml/8fl. oz. jars due to undeclared tadalafil. The product was distributed nationwide through the third-party e-commerce marketplace Amazon.com.
For consumers who may still hold the product, FDA records list the identifying codes as Batch No: ENGOT24 EXP: OCT 2028 UPC: 1234561870003. FDA enforcement records show no other enforcement actions for AKKARCO LLC.
Aug 18, 2026, 10:13 a.m. ETFirst report
FDA Classifies Recall of Ashfiat Alharamain Energy Support as Class I
On August 12, 2026, official FDA enforcement notices classified the recall of Ashfiat Alharamain Energy Support 250ml/8fl. oz. as Class I. The recall was originally initiated on January 28, 2026, by firm AKKARCO LLC due to undeclared tadalafil. The status of the recall remains open and developing.
According to FDA definitions, a Class I recall is the agency's most serious category, used where there is a reasonable probability that using the product will cause serious harm or death. Official documents show 1052 units are subject to the recall, distributed nationwide through third-party e-commerce marketplace Amazon.com.
The affected product is a honey-based dietary supplement packaged in a 250 ml (8 fl. oz.) jar or bottle. It is identified by recall number H-1196-2026, Batch No: ENGOT24, EXP: OCT 2028, and UPC: 1234561870003. Reporting from the Ohio Department of Health, Food Safety News, ABC7, and NewsNation notes the item was sold directly to consumers online and in retail stores. Agency databases list no other enforcement actions for AKKARCO LLC.
Was this report accurate and useful?
Sources
- https://api.fda.gov/food/enforcement.json?search=recall_number:%22H-1196-2026%22
- https://www.fda.gov/safety/industry-guidance-recalls/recalls-background-and-definitions
- https://odh.ohio.gov/know-our-programs/food-safety-program/food-recalls/02-04-2026-Akkarco-LLC
- https://www.foodsafetynews.com/2026/02/energy-supplement-recalled-because-of-undeclared-drug/
- https://www.newsnationnow.com/us-news/recalls/honey-recalled-erectile-dysfunction-tadalafil/
Revision history
- Version 118 Aug 2026, 14:59current
First published.
- Version 118 Aug 2026, 14:13current
First published.
- Version 118 Aug 2026, 14:56current
First published.
- Version 118 Aug 2026, 14:29current
First published.
How we work
This site models an investigative reporter rather than a wire desk. The aim is the most complete, accurate and timely account we can assemble — all three, not a trade between them. Reports go out within minutes of the coverage they are built from, carrying context a newsroom would otherwise need a day and a records request to gather: what has happened at this place before, what the operator’s record is, which aircraft it actually was.
Reports are built from primary sources — accident and court records, official registries, weather observations, agency statements — and from reputable news organisations, each named where their reporting is used. Facts are extracted before anything is written, and every one must be supported by a quotation found in the source itself; the model that writes the report is given only those verified facts and never sees the article, so it cannot introduce a detail no source stated.
Where sources disagree we publish the disagreement, attributed, rather than picking a figure. Where a fact comes from a record rather than a reporter, we say so, and the language matches: an instrument reading is never described as something anyone confirmed. Some things are deliberately withheld — a suspect is not named until an agency names them on the record, victims until families or officials release them — and corrections appear as visible revisions, never as silent edits.
None of that makes a report true. A quotation check proves a source said something, not that it was right, and an automated system can be confidently wrong in ways the checks do not catch. If something here is wrong, the feedback above is how it gets found. The full methodology, including what we refuse to publish.